Ursprung des Netzwerks ersten Grades von Bruce Hovanes
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Shearwater Corp.
 Shearwater Corp. Pharmaceuticals: MajorHealth Technology Part of Nektar Therapeutics, Shearwater Corp. is a company that provides research services focused on health care applications of advanced PEGylation. The company is based in Huntsville, AL. The company was founded by James R. Hudson, J. Milton Harris. Shearwater was acquired by Nektar Therapeutics on July 02, 2001 for $164.50 million.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Bruce Hovanes
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| ONCOLOGY PHARMA INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| AVALO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
| DELCATH SYSTEMS, INC. | Medical Specialties | Director/Board Member | |
Atlantic Research Group, Inc.
 Atlantic Research Group, Inc. Miscellaneous Commercial ServicesCommercial Services Atlantic Research Group, Inc. operates as a rare disease-focused contract research organization that provides comprehensive clinical program development services ranging from pre-launch consulting to commercialization. It offers strategic consulting, clinical trial management services, clinic data and analytics solutions, pharmacovigilance and medical monitoring. The company was founded by Paul Bishop and Lyle Camblos in 2004 and is headquartered in Charlottesville, VA. | Miscellaneous Commercial Services | Director/Board Member | |
Ballantyne Therapeutics, Inc.
 Ballantyne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ballantyne Therapeutics, Inc. manufactures pharmaceuticals. The private company is based in Charlotte, NC. | Pharmaceuticals: Major | Director/Board Member | |
| ATHENEXPAR | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CHELSEA THERAPEUTICS INTERNATIONAL LTD. | Biotechnology | Founder | |
| University of Saskatchewan College of Medicine | College/University | Doctorate Degree | |
| Eboo Pharmaceuticals, Inc. | Director/Board Member | ||
| CELLECTAR BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| Concordia University | College/University | Graduate Degree | |
| The University of Waterloo | College/University | Undergraduate Degree | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Nirogy Therapeutics, Inc.
 Nirogy Therapeutics, Inc. BiotechnologyHealth Technology Nirogy Therapeutics, Inc. is an American biotechnology company that operates in the healthcare industry. The company is based in N/A. The company was founded in 2014 by Vincent Sandanayaka, Jaime Escobedo. Simon C. Pedder has been the CEO of the company since 2022. | Biotechnology | Chief Executive Officer |
Statistik
International
| Vereinigte Staaten | 16 |
| Kanada | 4 |
Sektoral
| Health Technology | 13 |
| Consumer Services | 4 |
| Finance | 2 |
| Commercial Services | 2 |
Operativ
| Director/Board Member | 9 |
| President | 5 |
| Corporate Officer/Principal | 5 |
| Chief Executive Officer | 5 |
| Independent Dir/Board Member | 3 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Simon Pedder | 19 |
- Börse
- Insiders
- Bruce Hovanes
- Unternehmensverbindungen
